Literature DB >> 22955525

The role of backward mutations on the within-host dynamics of HIV-1.

John M Kitayimbwa1, Joseph Y T Mugisha, Roberto A Saenz.   

Abstract

The quality of life for patients infected with human immunodeficiency virus (HIV-1) has been positively impacted by the use of antiretroviral therapy (ART). However, the benefits of ART are usually halted by the emergence of drug resistance. Drug-resistant strains arise from virus mutations, as HIV-1 reverse transcription is prone to errors, with mutations normally carrying fitness costs to the virus. When ART is interrupted, the wild-type drug-sensitive strain rapidly out-competes the resistant strain, as the former strain is fitter than the latter in the absence of ART. One mechanism for sustaining the sensitive strain during ART is given by the virus mutating from resistant to sensitive strains, which is referred to as backward mutation. This is important during periods of treatment interruptions as prior existence of the sensitive strain would lead to replacement of the resistant strain. In order to assess the role of backward mutations in the dynamics of HIV-1 within an infected host, we analyze a mathematical model of two interacting virus strains in either absence or presence of ART. We study the effect of backward mutations on the definition of the basic reproductive number, and the value and stability of equilibrium points. The analysis of the model shows that, thanks to both forward and backward mutations, sensitive and resistant strains co-exist. In addition, conditions for the dominance of a viral strain with or without ART are provided. For this model, backward mutations are shown to be necessary for the persistence of the sensitive strain during ART.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22955525      PMCID: PMC4909148          DOI: 10.1007/s00285-012-0581-2

Source DB:  PubMed          Journal:  J Math Biol        ISSN: 0303-6812            Impact factor:   2.259


  31 in total

1.  Production of resistant HIV mutants during antiretroviral therapy.

Authors:  R M Ribeiro; S Bonhoeffer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

Review 2.  Modelling viral and immune system dynamics.

Authors:  Alan S Perelson
Journal:  Nat Rev Immunol       Date:  2002-01       Impact factor: 53.106

3.  Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission.

Authors:  P van den Driessche; James Watmough
Journal:  Math Biosci       Date:  2002 Nov-Dec       Impact factor: 2.144

Review 4.  Competition between zidovudine-sensitive and zidovudine-resistant strains of HIV.

Authors:  A R McLean; M A Nowak
Journal:  AIDS       Date:  1992-01       Impact factor: 4.177

5.  Dynamical models of tuberculosis and their applications.

Authors:  Carlos Castillo-Chavez; Baojun Song
Journal:  Math Biosci Eng       Date:  2004-09       Impact factor: 2.080

Review 6.  Dynamics of HIV-1 and CD4+ lymphocytes in vivo.

Authors:  A S Perelson; P Essunger; D D Ho
Journal:  AIDS       Date:  1997       Impact factor: 4.177

7.  Pre-existence and emergence of drug resistance in HIV-1 infection.

Authors:  S Bonhoeffer; M A Nowak
Journal:  Proc Biol Sci       Date:  1997-05-22       Impact factor: 5.349

8.  Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis.

Authors:  B Ramratnam; S Bonhoeffer; J Binley; A Hurley; L Zhang; J E Mittler; M Markowitz; J P Moore; A S Perelson; D D Ho
Journal:  Lancet       Date:  1999-11-20       Impact factor: 79.321

9.  A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo.

Authors:  Martin Markowitz; Michael Louie; Arlene Hurley; Eugene Sun; Michele Di Mascio; Alan S Perelson; David D Ho
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

10.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.

Authors:  L M Mansky; H M Temin
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

View more
  4 in total

1.  Immunology in Africa.

Authors:  Stephen Cose; Bernard Bagaya; Barbara Nerima; Moses Joloba; Andrew Kambugu; Robert Tweyongyere; David W Dunne; Edward Mbidde; Pontiano Kaleebu; Alison M Elliott
Journal:  Trop Med Int Health       Date:  2015-10-12       Impact factor: 2.622

2.  Estimation of the HIV-1 backward mutation rate from transmitted drug-resistant strains.

Authors:  J M Kitayimbwa; J Y T Mugisha; R A Saenz
Journal:  Theor Popul Biol       Date:  2016-08-20       Impact factor: 1.570

3.  Employing phylogenetic tree shape statistics to resolve the underlying host population structure.

Authors:  Hassan W Kayondo; Alfred Ssekagiri; Grace Nabakooza; Nicholas Bbosa; Deogratius Ssemwanga; Pontiano Kaleebu; Samuel Mwalili; John M Mango; Andrew J Leigh Brown; Roberto A Saenz; Ronald Galiwango; John M Kitayimbwa
Journal:  BMC Bioinformatics       Date:  2021-11-10       Impact factor: 3.169

4.  Career development for infection and immunity research in Uganda: a decade of experience from the Makerere University - Uganda Virus Research Institute research and training programme.

Authors:  Damalie Nakanjako; Flavia Zalwango; Pamela Wairagala; Fiona Luboga; Irene Andia Biraro; Victoria Diana Bukirwa; Mary Gorrethy Mboowa; Steve Cose; Janet Seeley; Alison Elliott
Journal:  AAS Open Res       Date:  2020-08-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.